Trial intelligence / Profile preview

High-Dose NRT for Quitting Cigarettes and E-cigarettes

NCT07754578Phase 2Not yet recruiting

Sponsor
Medical University of South Carolina
Start
Nov 2026
Primary completion
Apr 2030
Countries
1
01

Overview

Phase 2, randomised trial of nicotine patch in nicotine dependence (3 arms), sponsored by Medical University of South Carolina. Primary endpoints: Dual use abstinence at 24 weeks and Cigarette abstinence at 24 weeks. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

nicotine patch
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on NCT07754578.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07754578.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call